Product Program year 2025 Source: CMS Open Payments

Azmiro

Drug Endocrinology

NDC 24338-055-01

Open in the dashboard

General payments

$30,313

1,591 payments

Research payments

$0

0 payments

Through program year 2025, $30,313 in general payments and $0 in research payments were reported against Azmiro (Endocrinology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $30,046 1,577
2024 General $266 14

Breakdown

Who paid General payments · program years 2024–2025
  1. CutisPharma, Inc. $30,313 1,591 payments
Top recipients General payments · program year 2025
  1. Rigoberto Franco Internal Medicine · Miami, FL $136 <1% · 6 payments
  2. Darren Bruck Urology · Doral, FL $117 <1% · 5 payments
  3. Miguel Castillo Santiago Nurse Practitioner, Family · Houston, TX $104 <1% · 5 payments
  4. Francisco Gelpi-Hammerschmidt Urology · Houston, TX $103 <1% · 5 payments
  5. Gregory Hester Urology · Houston, TX $101 <1% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $9,013 31% · 335 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $4,354 15% · 169 practitioners
  3. Family Medicine $3,634 12% · 170 practitioners
  4. Physician Assistant $3,133 11% · 124 practitioners
  5. Internal Medicine $2,972 10% · 108 practitioners

The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $4,729 16% · 187 recipients
  2. Florida $2,293 8% · 81 recipients
  3. Virginia $2,213 7% · 95 recipients
  4. North Carolina $1,931 6% · 61 recipients
  5. Ohio $1,465 5% · 45 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,591 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record